Applying DALY to assessing national health insurance performance: the relationship between the national health insurance expenditures and the burden of disease measures in Iran
Version of Record online: 10 JUN 2005
Copyright © 2005 John Wiley & Sons, Ltd.
The International Journal of Health Planning and Management
Volume 20, Issue 2, pages 89–98, April 2005
How to Cite
Russel, M. (2005), Applying DALY to assessing national health insurance performance: the relationship between the national health insurance expenditures and the burden of disease measures in Iran. Int. J. Health Plann. Mgmt., 20: 89–98. doi: 10.1002/hpm.800
- Issue online: 10 JUN 2005
- Version of Record online: 10 JUN 2005
- burden of disease;
- health insurance;
- health priorities/standards;
- epidemiologic factors;
- health status indicators;
- costs and cost analysis;
- health care financing;
The Iranian government has considered using DALYs as an indicator to prioritize health service expenditures to reduce the burden of disease for the public.
A cross-sectional study was designed to compare several measures of the burden of disease with the actual amounts of national health insurance (NHI) expenditures, in one province of Iran (Semnan) for a period of 2 months (September 2000 and February 2001). Furthermore, on the basis of the research findings, a questionnaire was designed and distributed to stakeholders at local and national levels to explore their ideas about the gap between the expenditures of the diseases group and their burden. A semi-structured interview was conducted to elicit participants' views on the research findings.
The results of this study have revealed that, currently, there is no strong relation between the NHI expenditures and DALY (r = 0.41, p = 0.09), but that there are stronger relationships between the amounts of NHI reimbursements with YLL (r = 0.52, p < 0.05), mortality (r = 0.67, p < 0.01) and hospital days (r = 0.90, p < 0.01). Comparing each group of disorders' DALY with the resources allocated to them (cost per DALY) it was shown that diabetes mellitus, musculoskeletal diseases, maternal conditions, sense organ disorders received considerably generous funding; and, perinatal conditions, congenital abnormalities, nutritional deficiencies were relatively under-funded.
The qualitative research results showed that the majority of respondents agreed that the differences presently existing between disorders' burden and NHI expenditures cannot be justified; and, further, that reducing the overall burden of disease must be one of the most important objectives for the NHI. Copyright © 2005 John Wiley & Sons, Ltd.